Steven Prelack, Director at GALECTIN THERAPEUTICS INC (GALT), sold 6,000 shares at $11.84 ($71K) on 2014-04-11, disclosed to the SEC on 2014-04-14.
Open-market sale of $71k GALT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.